Table 2 Baseline characteristics
Traditional care | Tailored nurse-led care | P-value | |
|---|---|---|---|
Number of patients: | 105 | 112 | |
Demographics: | |||
• Men | n = 57, 71% | n = 83, 74% | 0.67 |
• Age, years | 61.7 (±9.1) | 61.8 (±8.0) | 0.10 |
Risk factors: | |||
• Diabetes Mellitus | n = 33, 31% | n = 21, 19% | 0.10 |
• Active smoker | n = 43, 41% | n = 40, 36% | 0.35 |
• SBP, mmHg | 149.9 (±32.2) | 153.7 (±24.2) | 0.33 |
• DBP, mmHg | 87.1 (±17.3) | 87.4 (±15.2) | 0.90 |
• BMI, kg/m2 | 27.3 (±4.5) | 27.9 (±4.5) | 0.37 |
• Total cholesterol, mmol/L | 5.0 (±1.2) | 4.6 (±1.0) | 0.01 |
• LDL, mmol/L | 3.0 (±1.2) | 2.7 (±0.9) | 0.45 |
• HDL, mmol/L | 1.2 (±0.4) | 1.2 (±0.4) | 0.19 |
• TG, mmol/L | 1.8 (±1.3) | 1.5 (±0.7) | 0.07 |
LVEF at the time of index event | |||
• Normal (≥50%) | n = 68, 65% | n = 88, 79% | 0.09 |
• Mildly decreased (40–49%) | n = 20, 19% | n = 17, 15% | |
• Moderately decreased (30–39%) | n = 8, 8% | n = 4, 4% | |
• Severely decreased (≤29%) | n = 3, 3% | n = 0 | |
History of cardiovascular disease: | |||
AMI, PCI or CABG | n = 19, 18% | n = 22, 20% | 0.83 |
Type of myocardial infarction | |||
• NSTEMI | n = 74, 70% | n = 73, 65% | 0.40 |
• STEMI | n = 31, 30% | n = 38, 34% | 0.49 |
Number of vessels affected | |||
• No significant stenosis | n = 7, 16% | n = 4, 10% | 0.44 |
• 1–2 affected vessels | n = 23, 51% | n = 27, 64% | |
• 3 affected vessels or left main stenosis | n = 15, 33% | n = 11, 26% | |
In-hospital treatment: | |||
• PCI | n = 81, 77% | n = 85, 76% | 0.62 |
• CABG | n = 12, 11% | n = 20, 18% | 0.25 |
Pharmacological treatment at hospital discharge: | |||
• Platelet inhibitors | n = 105, 100% | n = 111, 99% | 0.33 |
• Statins | n = 104, 99% | n = 110, 98% | 0.97 |
• Ezetimibe | n = 1, 1% | n = 1, 1% | 0.62 |
• ACEi or ARB | n = 103, 98% | n = 103, 92% | 0.06 |
• Β-blockers | n = 91, 87% | n = 96, 86% | 0.62 |